Home › Companies › Benitec Biopharma Inc.

Benitec Biopharma Inc. (BNTC) proxy voting records

How asset managers voted at Benitec Biopharma Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

TickerBNTC
CUSIP issuer number08205P
SEC CIK1808898

Recent shareholder votes

December 1, 2025 annual meeting (2025-2026 proxy season): 4 items in Benitec Biopharma Inc.'s official results (Form 8-K, filed December 2, 2025); lowest support 78% of votes cast (Advisory Vote on Executive Compensation). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Season	Filed as	Ballot items	Asset managers
2025-2026	Benitec Biopharma Inc.	4	76

Explore Benitec Biopharma Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on November 6, 2026. This page is rebuilt weekly; built November 9, 2026.